Retiro De Equipo (Recall) de DuraClone B27 Reagent Kit - an in vitro medical device

Según Department of Health, Therapeutic Goods Administration, este evento ( retiro de equipo (recall) ) involucró a un dispositivo médico en Australia que fue producido por Beckman Coulter Australia Pty Ltd.

¿Qué es esto?

Una corrección al equipo o acción de retiro tomada por el fabricante para abordar un problema con un dispositivo médico. Los retiros (recalls) ocurren cuando un dispositivo médico está defectuoso, cuando puede poner en riesgo la salud, o cuando simultáneamente está defectuoso y puede poner en riesgo la salud.

Más información acerca de la data acá
  • Tipo de evento
  • ID del evento
  • Clase de Riesgo del Evento
    Class II
  • Fecha de inicio del evento
  • País del evento
  • Fuente del evento
  • URL de la fuente del evento
  • Notas / Alertas
    Australian data is current through July 2018. All of the data comes from the Australian Therapeutic Goods Administration, except for the categories Manufacturer Parent Company and Product Classification.
    The Parent Company and the Product Classification were added by ICIJ.
    The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of recall data from the U.S. and Australia.
  • Notas adicionales en la data
  • Causa
    As a result of internal investigations, beckman coulter has determined that certain duraclone b27 reagent kits have a defect that may generate false negative results in some samples. this defect is most likely to affect samples with mfi values between 10 to 19 when tested on navios/cytomics fc 500 cytometers and channel values between 517 to 602 when tested on bd facscalibur/ bc facscan cytometers.There has been no report of death or injury related to this defect.
  • Acción
    Beckman Coulter is advising users to run tests of lot numbers 050917, 070417_11, 090517, 120617_02, 170417_09, 170417_11, 170417_11, 190617 and 240717 with the new determinant and indeterminant zone values provided with the Customer Letter. Other affected lot numbers should be disposed of in an appropriate manner. Affected customers may contact their local Beckman Coulter representative for replacement product. Beckman Coulter recommends if required, redetermination of those results obtained for the above specified 8 lot numbers using the new determinant values outlined in the Customer Letter. For all lot numbers, Beckman Coulter recommend samples previously reported as ‘negative’ to be verified using alternate methods such as PCR if considered necessary.


  • Modelo / Serial
    DuraClone B27 Reagent Kit - an in vitro medical deviceRef Number: B36862Multiple Lot Numbers AffectedARTG 224373
  • Manufacturer